Start Date
August 31, 2004
Primary Completion Date
November 30, 2006
Study Completion Date
December 31, 2006
Everolimus
Novartis Investigational Site, Various Cities
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY